Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupport

Search

Close

Enter Search Terms

Malissa Magiera

Malissa Magiera

ID: 1b83a53d-2619-30fb-68c4

/

Claimed Record

/

Organization: Rothwell Figg

Solicitor General Urges the Supreme Court to Reverse the Federal Circuit’s <em>Teva v. GSK </em>Decision

Biosimilars Law Bulletin · April 18, 2023

Foodtech Patents: Who’s on the Board and What Moves are they Making?

RF EMerge · March 29, 2023

<i>Amgen v. Sanofi</i> Case on Enablement of Antibody Genus Claims Will be Heard at the Supreme Court; <i>Cert</i> Denied in <i>Juno v. Kite</i>

Biosimilars Law Bulletin · November 7, 2022

Tysabri® (natalizumab) Litigation Begins

Biosimilars Law Bulletin · September 15, 2022

Purple Book Update – Regeneron’s EYLEA (aflibercept)

Biosimilars Law Bulletin · June 7, 2022

Previous

12

Next

Practice Areas

Health Care and Life Sciences

Business and Commercial

Jurisdictions

Washington, D.C.

Publishing Record

Publisher Since 2021

Total Articles 9

Most Recent April 18, 2023

Cite This Author

Malissa Magiera, Rothwell Figg

LexBlog Author ID:

1b83a53d-2619-30fb-68c4

www.lexblog.com/author/mmagiera

Contact

FirmRothwell Figg

Emailmmagiera@rfem.com

BlogsBiosimilars Law Bulletin

LinkedInView Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog